The FDA has authorized Apple’s AirPods Pro 2 to function as over-the-counter hearing aids, aimed at users with mild to moderate hearing loss. This feature was announced at Apple’s “Glowtime” event and is expected to be available this fall following global regulatory approval. The new functionality could significantly impact the hearing aid market, valued at $13 billion, by providing a more accessible and affordable option compared to traditional hearing aids. Apple also revealed plans to include sleep apnea detection in its Apple Watch, furthering its push into health technology. These advancements align with Apple's broader strategy to integrate health-focused features into its popular consumer devices. However, the new hearing aid feature may not be suitable for those with severe hearing loss, who will still need professional medical consultation.